Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Imfinzi Approved in the US as First and Only Immunotherapy Regimen for Patients with Limited-Stage Small Cell Lung Cancer

AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC)...

FDA Grants Accelerated Approval to Bizengri (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) [Merus, the Company, we, or our], a clinical-stage...

FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara

 Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced...

Most U.S. Adults Want to Be Asked About Mental Health at Primary Care Visits

Seven in 10 U.S. adults would prefer to be asked about both their physical and mental health during medical appointments with primary care providers (PCPs),...

Biomarkers of Insulin Resistance Are Risk Factors for Aortic Stenosis

Biomarkers of insulin resistance are risk factors for aortic stenosis (AS), according to a study published online Nov. 27 in the Annals of Medicine. Maija...

RSNA: Opportunistic Assessment of Aortic Calcium Predicts MACE

A fully automated algorithm to quantify aortic artery calcification (AAC) on computed tomography (CT) scans performed for other clinical purposes (opportunistic...

Itacitinib Helps Prevent Graft Versus Host Disease in Stem Cell Transplant Recipients

For patients with haploidentical hematopoietic cell transplantation (haplo-HCT), the addition of itacitinib to standard graft versus host disease (GvHD)...

EPA Bans Two Solvents Linked to Cancer

Two commonly used solvents that have been linked to cancer were banned Monday by the Environmental Protection Agency. The solvents, known as trichloroethylene...

Trump Says RFK Jr. Free to Revisit Discredited Autism/Vaccine Link

If Robert F. Kennedy Jr. is approved to head the U.S. Department of Health and Human Services, he will be free to revisit a long-debunked link between...

High-Fiber Diet May Prevent a Blood Cancer in People at High Risk

People who have a condition putting them at high risk for a bone marrow cancer may be able to ward off the malignancy with a high-fiber diet, new research...

Dolphins Are Testing Positive for Fentanyl

Most Americans understand how deeply the dangerous opioid fentanyl has permeated the illicit drug market. Now, it's even infiltrated the bodies of Gulf...

Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma

(BUSINESS WIRE) December 8, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of...

Phase 2 Data From the Ongoing Hibiscus Study Shows Promise That Investigational Etavopivat Could Reduce the Incidence of Vaso-occlusive Crises in People With Sickle Cell Disease

Novo Nordisk today announced 52-week results from the phase 2 part of the ongoing phase 2/3 HIBISCUS study program of investigational etavopivat in people...

Elton John Says He Has Lost His Sight

Pop music legend Elton John says that he can no longer see following an eye infection he battled last summer. The prolific singer-songwriter made the...

Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug...

Read more news...

Recently Added

Recently added consumer and prescribing information: Yesintek, Revuforj, Danziten, Aucatzyl, Emrosi, Imuldosa, Hympavzi, Flyrcado, Otulfi, Tecentriq Hybreza

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Bizengri Bizengri (zenocutuzumab-zbco) is a bispecific HER2- and HER3-directed antibody for the treatment of patients with neuregulin 1 fusion...
  • Yesintek Yesintek (ustekinumab-kfce) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...
  • Rapiblyk Rapiblyk (landiolol) is an ultra-short acting cardioselective beta-1 adrenergic blocker for for the short-term reduction of ventricular...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...

More drugs in development